University of Missouri School of Medicine Researchers Further Understanding of Acute Lymphoblastic Leukemia (Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute ...)

Press/Media: Research

PeriodJul 3 2024

Media coverage

1

Media coverage

  • TitleUniversity of Missouri School of Medicine Researchers Further Understanding of Acute Lymphoblastic Leukemia (Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute ...)
    Media name/outletGenomics & Genetics Daily
    Country/TerritoryUnited States
    Date3/7/24
    PersonsMeenakshi Devidas
View all 1
View less